SCI ADV 润色咨询

Science Advances

出版年份:暂无数据 年文章数:9282 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:1.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2026-07-22 ms4049850445287163 来自西弗吉尼亚

    审稿速度:24.0 | 投稿命中率:50.0
    偏重的研究方向:医学
    经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-06-05 ms7566810229389751 来自江苏省

    偏重的研究方向:生物学
    经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-12-02 Leeeeeeee

    审稿速度:2.0
    偏重的研究方向:血管衰老
    经验分享:10.16 submitted
    10.28 to review
    11.26 from all reviewers
    已经一周了没变化,好慌

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-06-24 Zhudingding 来自北京

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-06-03 Mr.Never Die 来自上海

    搞笑杂志,编辑水平就是一坨大便

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-03-31 ms3000001687948380 来自浙江省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:代谢工程;合成生物学;发酵调控
    经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2025-01-20 ms8000001656880339 来自北京

    在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2017-12-28 CR10

    Nature Communications: 73591/(6721+15) = 10.925
    Science Advances: 6814/(726+15) = 9.195
    Developmental Cell: 3635/(372+38) = 8.865
    PNAS: 55771/6468 = 8.622
    Cell Reports: 13710/1866 = 7.347
    eLife: 13222/1979 = 6.681


    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2024-11-14 ms8000001611048358 来自广东省

    审稿速度:3.0
    经验分享:12

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2347251, encodeId=245a234e251eb, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:投了一篇。医学口的文章处理效率非常低,非常非常低。from author了快3周后editor才开始评估。Under Evaluation了又3个多周,看样子editor有一搭没一搭的也不是很负责。最后实在不想等了,找了个理由撤回来了。后面投了专业杂志,2个月外审都回来了。收费最高的两个杂志,NC和SA,目前成了效率最低的两个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d81831541, createdName=ms4049850445287163, createdTime=Wed Jul 22 19:18:09 CST 2026, time=2026-07-22, status=1, ipAttribution=西弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2268012, encodeId=5f56226801269, content=偏重的研究方向:生物学<br>经验分享:under evaluation两个多星期了,不知还要等多久才能知道能不能过初审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E400B6EBDFCF3FDB06DB0E6AB8CF8B7/100, createdBy=c7fb2501293, createdName=ms7566810229389751, createdTime=Thu Jun 05 10:53:49 CST 2025, time=2025-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2291574, encodeId=682622915e462, content=审稿速度:2.0<br>偏重的研究方向:血管衰老<br>经验分享:10.16 submitted<br>10.28 to review<br>11.26 from all reviewers<br>已经一周了没变化,好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0b75538624, createdName=Leeeeeeee, createdTime=Tue Dec 02 16:54:13 CST 2025, time=2025-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2270641, encodeId=209b22e064169, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:还挺顺利的,编辑和审稿人都挺友好。从投稿到To External大概7个月,期待上线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57121645592, createdName=Zhudingding, createdTime=Tue Jun 24 11:18:20 CST 2025, time=2025-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2267810, encodeId=3e0c226e810c9, content=搞笑杂志,编辑水平就是一坨大便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Jun 03 18:00:04 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2258525, encodeId=7b88225852589, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:代谢工程;合成生物学;发酵调控<br>经验分享:24号开始 Under Evaluation,26,28分别动了一下日期,今天31号还是Under Evaluation,点进去看发现Editor Evaluation Completed,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e69688758, createdName=ms3000001687948380, createdTime=Mon Mar 31 15:13:14 CST 2025, time=2025-03-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248945, encodeId=d92c22489452e, content=在home页面显示Under Evaluation,但是点进去文章稿件名之后,显示Status: Reviewer Invited是已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Mon Jan 20 22:44:21 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=550438, encodeId=32c7550438f6, content=Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=676, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96201620396, createdName=CR10, createdTime=Thu Dec 28 20:46:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236836, encodeId=910d223683628, content=审稿速度:3.0<br>经验分享:12, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45909346082, createdName=ms8000001611048358, createdTime=Thu Nov 14 00:15:36 CST 2024, time=2024-11-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=861823, encodeId=7f2786182372, content=审稿速度:4.0<br>经验分享:20200127 投稿<br> 20200327 第一轮修改,三个审稿人(两个小修,一个大修)<br> 20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)<br> 20200528 accept-technical hold<br> 20200602 付版面费 4500 usd<br> 20200612 accepted<br> 希望对投稿的人有所帮助!!! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2318, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Sat Jun 13 11:06:00 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-06-13 ms3036779279854874

    审稿速度:4.0
    经验分享:20200127 投稿
    20200327 第一轮修改,三个审稿人(两个小修,一个大修)
    20200505 第一轮修改,三个审稿人(两个同意接收,一个小修)
    20200528 accept-technical hold
    20200602 付版面费 4500 usd
    20200612 accepted
    希望对投稿的人有所帮助!!!

    7

    展开7条回复
共108条页码: 1/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分